Interstitial Lung Disease Associated

计划入组 1,000 人 · 首次发布于 2023 年 8 月 23 日

Interstitial Lung Disease Registry Construction

计划入组 300 人 · 首次发布于 2017 年 8 月 3 日

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

计划入组 58 人 · 首次发布于 2015 年 12 月 21 日

anti-inflammatory agent (rheumatoid arthritis associated interstitial lung disease)

Nintedanib(Ofev, Vargatef, Nintedanib Accord, Nintedanib Viatris)

C₃₁H₃₃N₅O₄

FP-045

Lung Therapeutics, Inc.

United States

Sec Lung, LLC

United States

Lung Healing Technologies Inc

United States

Oncology Nurses Key to Managing T-DXd Side Effects, Including Interstitial Lung Disease

ILD Day 2026 Spotlights Precision Medicine's Potential to Transform Interstitial Lung Disease Care

FDA Grants Fast Track Designation to 99mTc-Maraciclatide for Interstitial Lung Disease Imaging